Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery

Not Applicable

Recruiting

Conditions: Prostate Cancer
Erectile Dysfunction

Interventions: Behavioral: questionnaires
Behavioral: three in-person sessions
Behavioral: monthly phone calls
Behavioral: Acceptance and Commitment Therapy for Erectile Dysfunction (ACT-ED)
Behavioral: Enhanced Monitoring and Education (EME)

First Posted Date: 2016-03-11

Last Posted Date: 2024-07-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 224

Registration Number: NCT02706561

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Taxi METERS: Measuring Effectiveness of Technology, Education, Referrals and Support

Not Applicable

Active, not recruiting

Conditions: Improving Blood Pressure Control

Interventions: Other: Heal th Fair + TECH [Text Messaging + Home Blood Pressure Monitoring] + Social Network Support (SNS)
Other: Health Fair + TECH [Text Messaging + Home Blood Pressure Monitoring]
Other: CONTROL- Usual & Customary Health Fair Follow-up

First Posted Date: 2016-03-08

Last Posted Date: 2024-03-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 166

Registration Number: NCT02701829

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Electronic Reporting of Symptoms After Surgery

Completed

Conditions: Patients Scheduled to Undergo Surgery on the Gynecology Service

Interventions: Behavioral: survey

First Posted Date: 2016-03-07

Last Posted Date: 2019-11-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 135

Registration Number: NCT02700256

Locations: 🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Rockville Centre, Rockville Centre, New York, United States

and more 2 locations

Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study

Phase 1

Completed

Conditions: High Risk Smoldering Multiple Myeloma
Multiple Myeloma

Interventions: Drug: Ixazomib (MLN9708)
Drug: Dexamethasone

First Posted Date: 2016-03-03

Last Posted Date: 2024-05-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 14

Registration Number: NCT02697383

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 2 locations

Emotion Regulation Therapy to Address Distress Among Caregivers

Completed

Conditions: Care Givers

Interventions: Behavioral: Psychosocial Instruments
Behavioral: Emotion Regulation Therapy for Cancer Caregivers (ERT-C)

First Posted Date: 2016-03-03

Last Posted Date: 2020-07-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 32

Registration Number: NCT02697357

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Trial of a Social Marketing Campaign to Increase HPV Vaccination Among Mexican American Children

Active, not recruiting

Conditions: HPV Vaccination

Interventions: Behavioral: Assessments
Other: No Text Messaging
Other: Text Message Reminder

First Posted Date: 2016-03-03

Last Posted Date: 2024-04-17

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 181

Registration Number: NCT02697396

Locations: 🇺🇸
Consulate General of Mexico in New York, New York, New York, United States

Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Phase 2

Completed

Conditions: Head and Neck Squamous Cell Carcinoma (HNSCC)

Interventions: Drug: Nivolumab
Radiation: Stereotactic Body Radiation Therapy (SBRT)

First Posted Date: 2016-02-17

Last Posted Date: 2022-03-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 65

Registration Number: NCT02684253

Locations: 🇺🇸
Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 3 locations

Negative Pressure Wound Therapy in Post-Operative Incision Management

Phase 3

Completed

Conditions: Negative-Pressure Wound Therapy

Interventions: Other: dry gauze
Device: The Prevena Incision Management System

First Posted Date: 2016-02-15

Last Posted Date: 2024-01-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 577

Registration Number: NCT02682316

Locations: 🇺🇸
Lehigh Valley Health Network, Allentown, Pennsylvania, United States
🇺🇸
Memorial Sloan Kettering Commack (Consent and Follow-Up only), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau (Consent and Follow-Up only), Uniondale, New York, United States

and more 7 locations

Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia

Recruiting

Conditions: Relapsed
Acute Leukemia
Newly Diagnosed

Interventions: Other: assessments

First Posted Date: 2016-02-09

Last Posted Date: 2024-07-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1365

Registration Number: NCT02677064

Locations: 🇺🇸
Hartford Healthcare Cancer Institute @ Hartford Hospital, Hartford, Connecticut, United States
🇺🇸
Lehigh Valley Health Network, Allentown, Pennsylvania, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers

Phase 2

Recruiting

Conditions: Solid Tumor Cancers
Bladder Cancer
Lung Cancer
Urinary Tract Cancers

Interventions: Drug: ado-trastuzumab emtansine

First Posted Date: 2016-02-05

Last Posted Date: 2024-12-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 140

Registration Number: NCT02675829

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy